Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.

Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.

Ann Neurol. 2010 Aug;68(2):193-203. doi: 10.1002/ana.22043.

PMID:
20695012
2.

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

Runia TF, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ.

Neurology. 2012 Jul 17;79(3):261-6. doi: 10.1212/WNL.0b013e31825fdec7. Epub 2012 Jun 13.

PMID:
22700811
3.

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.

Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152-7. Epub 2007 Jun 19.

PMID:
17578859
4.

Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.

Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, Woodbaker R, Nunez M, Dwyer T, Taylor BV, Ponsonby AL.

Neuroepidemiology. 2008;31(4):271-9. doi: 10.1159/000166602. Epub 2008 Oct 30.

PMID:
18971584
5.

Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.

Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr.

J Am Geriatr Soc. 2009 Sep;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. Epub 2009 Jun 22.

PMID:
19549021
6.

25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.

Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A.

Mult Scler. 2005 Jun;11(3):266-71.

PMID:
15957505
7.

Immunomodulatory effects of Vitamin D in multiple sclerosis.

Correale J, Ysrraelit MC, Gaitán MI.

Brain. 2009 May;132(Pt 5):1146-60. doi: 10.1093/brain/awp033. Epub 2009 Mar 24.

8.

Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.

Lin R, Taylor BV, Simpson S Jr, Charlesworth J, Ponsonby AL, Pittas F, Dwyer T, van der Mei IA.

J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):399-404. doi: 10.1136/jnnp-2013-305245. Epub 2013 Jul 18.

PMID:
23868949
9.

Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women.

Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman Ch, Lips P.

Mult Scler. 2009 Jan;15(1):9-15. doi: 10.1177/1352458508095920. Epub 2008 Aug 13.

PMID:
18701572
10.

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study.

Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, Sea MM, Woo J.

Am J Clin Nutr. 2008 Jun;87(6):1631-8.

11.

Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission.

Visser M, Deeg DJ, Puts MT, Seidell JC, Lips P.

Am J Clin Nutr. 2006 Sep;84(3):616-22; quiz 671-2.

12.

Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.

Stewart N, Simpson S Jr, van der Mei I, Ponsonby AL, Blizzard L, Dwyer T, Pittas F, Eyles D, Ko P, Taylor BV.

Neurology. 2012 Jul 17;79(3):254-60. doi: 10.1212/WNL.0b013e31825fded9. Epub 2012 Jun 13.

PMID:
22700816
13.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.

Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R.

Mult Scler. 2008 Nov;14(9):1220-4. doi: 10.1177/1352458508094399. Epub 2008 Jul 24.

PMID:
18653736
14.

Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.

Simpson S Jr, Taylor B, Dwyer DE, Taylor J, Blizzard L, Ponsonby AL, Pittas F, Dwyer T, van der Mei I.

Mult Scler. 2012 Jun;18(6):799-806. doi: 10.1177/1352458511428081. Epub 2011 Nov 14.

PMID:
22084489
15.

Vitamin D as a protective factor in multiple sclerosis.

Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P.

Neurology. 2012 Nov 20;79(21):2140-5. doi: 10.1212/WNL.0b013e3182752ea8.

PMID:
23170011
16.

Safety of vitamin D3 in adults with multiple sclerosis.

Kimball SM, Ursell MR, O'Connor P, Vieth R.

Am J Clin Nutr. 2007 Sep;86(3):645-51.

17.

Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.

Brodin E, Lerstad G, Grimnes G, Brækkan SK, Vik A, Brox J, Svartberg J, Jorde R, Hansen JB.

Thromb Haemost. 2013 May;109(5):885-90. doi: 10.1160/TH12-10-0728. Epub 2013 Feb 28.

PMID:
23446951
18.

Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men.

Lee DM, Tajar A, Ulubaev A, Pendleton N, O'Neill TW, O'Connor DB, Bartfai G, Boonen S, Bouillon R, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Silman AJ, Vanderschueren D, Wu FC; EMAS study group.

J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):722-9. doi: 10.1136/jnnp.2008.165720. Epub 2009 May 21.

PMID:
19460797
19.

A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population.

Bang UC, Semb S, Nordgaard-Lassen I, Jensen JE.

Nutr Res. 2009 Sep;29(9):671-5. doi: 10.1016/j.nutres.2009.09.010.

PMID:
19854383
20.

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.

Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J.

Breast Cancer Res. 2011 Jul 26;13(4):R74. doi: 10.1186/bcr2920.

Items per page

Supplemental Content

Write to the Help Desk